Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	nuclear speck	USP36 PRPF3 RBBP6 GPATCH2 DACH1 CIR1 SRPK2 PASD1	4.93e-05	431	64	8	GO:0016607
GeneOntologyCellularComponent	nuclear protein-containing complex	PBRM1 PRPF3 CSNK2A2 TAF7L PYM1 TIMELESS ZCCHC7 PRKRIP1 PDCD7 TCF7L1 MED12 LARP7 PASD1	2.32e-04	1377	64	13	GO:0140513
MousePheno	lethality during fetal growth through weaning, complete penetrance	SLC43A2 HOXA13 AHI1 EVC2 SULF2 PBRM1 ANK2 MYO5A MYCBP2 DACH1 CHD2 TCF7L1 MEFV LARP7 TFPI CREB3L2	6.48e-06	1269	51	16	MP:0011111
Domain	Ski_Sno	DACH2 DACH1	2.48e-04	7	65	2	PF02437
Domain	-	DACH2 DACH1	2.48e-04	7	65	2	3.10.260.20
Domain	Transform_Ski	DACH2 DACH1	2.48e-04	7	65	2	IPR003380
Domain	DNA-bd_dom_put	DACH2 DACH1	6.43e-04	11	65	2	IPR009061
Domain	IQ	IQCF2 MYO5A MYO9B	1.94e-03	71	65	3	PF00612
Domain	IQ	IQCF2 MYO5A MYO9B	2.83e-03	81	65	3	SM00015
Domain	zf-CCHC	RBBP6 ZCCHC7	2.88e-03	23	65	2	PF00098
Domain	-	RBBP6 ZCCHC7	3.67e-03	26	65	2	4.10.60.10
Domain	Bromodomain_CS	PBRM1 ATAD2B	3.67e-03	26	65	2	IPR018359
Domain	IQ_motif_EF-hand-BS	IQCF2 MYO5A MYO9B	3.81e-03	90	65	3	IPR000048
Domain	IQ	IQCF2 MYO5A MYO9B	4.18e-03	93	65	3	PS50096
Domain	Helicase_C	DDX60 CHD2 DDX60L	6.17e-03	107	65	3	PF00271
Domain	HELICc	DDX60 CHD2 DDX60L	6.17e-03	107	65	3	SM00490
Domain	Helicase_C	DDX60 CHD2 DDX60L	6.33e-03	108	65	3	IPR001650
Domain	HELICASE_CTER	DDX60 CHD2 DDX60L	6.50e-03	109	65	3	PS51194
Domain	HELICASE_ATP_BIND_1	DDX60 CHD2 DDX60L	6.50e-03	109	65	3	PS51192
Domain	DEXDc	DDX60 CHD2 DDX60L	6.50e-03	109	65	3	SM00487
Domain	ZF_CCHC	RBBP6 ZCCHC7	6.59e-03	35	65	2	PS50158
Domain	Helicase_ATP-bd	DDX60 CHD2 DDX60L	6.66e-03	110	65	3	IPR014001
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	GTPBP4 PBRM1 MYO5A MYCBP2 PRPF3 MYO9B RBBP6 KTN1 EIF2B4 SRPK2 RPL14 PRC1 PDCD7 MED12 LARP7	1.28e-11	759	67	15	35915203
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	CEP350 GTPBP4 PBRM1 ANK2 CSNK2A2 KTN1 EIF2B4 GPATCH2 SRPK2 PYM1 CHD2 RPL14 PRKRIP1 PDCD7 ANKHD1 FKBP11 LARP7 TFPI	7.08e-11	1371	67	18	36244648
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	FANCD2 USP36 GTPBP4 SULF2 PBRM1 ZNF148 PRPF3 RBBP6 CSNK2A2 TAF7L GPATCH2 SRPK2 ANKHD1 TCF7L1 LARP7 NSD3	2.75e-10	1116	67	16	31753913
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	USP36 PBRM1 MYO5A RBBP6 CSNK2A2 MTRFR KTN1 SRPK2 PYM1 CHD2 EIF3A PDCD7 ANKHD1 MED12 LARP7 NSD3	1.80e-08	1497	67	16	31527615
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	GTPBP4 PBRM1 MYO5A MYCBP2 CSNK2A2 ATAD2B CHD2 RPL14 ANKHD1 MED12 LARP7	4.66e-08	653	67	11	22586326
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	GTPBP4 PBRM1 ZNF148 PRPF3 RBBP6 CSNK2A2 KTN1 SRPK2 EIF3A RPL14 LARP7 NSD3	7.08e-08	847	67	12	35850772
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	CEP350 USP36 FAM193A MYO5A MYCBP2 DDX60 KTN1 PYM1 PRC1 ANKHD1 TTC3	1.32e-07	724	67	11	36232890
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	USP36 GTPBP4 PBRM1 ZNF148 PRPF3 RBBP6 KTN1 CHD2 RPL14 ZCCHC7 PRC1 FKBP11 NSD3 CREB3L2	1.41e-07	1294	67	14	30804502
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	USP36 GTPBP4 FAM193A ZNF148 ANK2 PRPF3 RBBP6 KTN1 PYM1 EIF3A RPL14 ANKHD1	2.03e-07	934	67	12	33916271
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	USP36 GTPBP4 MYO5A MYCBP2 PRPF3 MYO9B KTN1 EIF2B4 CHD2 EIF3A RPL14 DDX60L ANKHD1 MED12	2.41e-07	1353	67	14	29467282
Pubmed	Interactome and Proteome Dynamics Uncover Immune Modulatory Associations of the Pathogen Sensing Factor cGAS.	MYO5A MYCBP2 DDX60 KTN1 CHD2 DDX60L LARP7	2.95e-07	228	67	7	30471916
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	GTPBP4 MYO5A PRPF3 RBBP6 SRPK2 PYM1 CHD2 EIF3A RPL14 ANKHD1 LARP7	3.86e-07	807	67	11	22681889
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	FANCD2 GTPBP4 PBRM1 PRPF3 RBBP6 CSNK2A2 CHD2 EIF3A PRC1 MED12 LARP7 NSD3	4.85e-07	1014	67	12	32416067
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	FANCD2 GTPBP4 PRPF3 MYO9B CSNK2A2 EIF2B4 ANKHD1 LARP7	5.08e-07	364	67	8	24778252
Pubmed	The protein interaction landscape of the human CMGC kinase group.	CEP350 FANCD2 RBBP6 CSNK2A2 TAF7L C16orf78 SRPK2 CHD2 MED12 LARP7	8.47e-07	695	67	10	23602568
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	RBBP6 CSNK2A2 KTN1 EIF2B4 CIR1 SRPK2 PYM1 EIF3A PRC1 PDCD7	9.15e-07	701	67	10	30196744
Pubmed	The histone acetyltransferase KAT6A is recruited to unmethylated CpG islands via a DNA binding winged helix domain.	CEP350 PBRM1 ZNF148 PRPF3 CSNK2A2 SRPK2 RPL14 ZCCHC7	1.40e-06	417	67	8	36537216
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	GTPBP4 PBRM1 MYCBP2 PRPF3 CSNK2A2 GPATCH2 SRPK2 PRC1	2.09e-06	440	67	8	34244565
Pubmed	Dual role of Med12 in PRC1-dependent gene repression and ncRNA-mediated transcriptional activation.	PRC1 MED12	3.66e-06	2	67	2	27096886
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	GTPBP4 FAM193A ZNF148 ANK2 MYO5A MYCBP2 KTN1 EIF2B4 SRPK2 PYM1 RPL14 TTC3 LARP7	4.45e-06	1487	67	13	33957083
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	GTPBP4 MYO5A PRPF3 RBBP6 DDX60 CSNK2A2 EIF2B4 SRPK2 EIF3A RPL14 PRC1 NSD3	4.50e-06	1257	67	12	36526897
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	USP36 GTPBP4 HOXA13 ZNF148 CSNK2A2 EIF3A LARP7	5.01e-06	349	67	7	25665578
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	USP36 GTPBP4 ZNF148 MYCBP2 RBBP6 SRPK2 EIF3A	6.24e-06	361	67	7	26167880
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	GTPBP4 SULF2 MYCBP2 PRPF3 RBBP6 CHD2 RPL14 PDCD7 FKBP11 MED12 NSD3	6.56e-06	1082	67	11	38697112
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	GTPBP4 PBRM1 ZNF148 MYO9B CSNK2A2 DACH1 CHD2 NSD3	8.52e-06	533	67	8	30554943
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	GTPBP4 PRPF3 RBBP6 CSNK2A2 EIF2B4 SRPK2 PYM1 RPL14 LARP7	9.00e-06	713	67	9	29802200
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ZNF148 MYCBP2 RBBP6 KTN1 DACH1 ANKHD1 MED12 NSD3	1.06e-05	549	67	8	38280479
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	GTPBP4 MYO5A PRPF3 RBBP6 CSNK2A2 SRPK2 EIF3A RPL14 PRC1	1.10e-05	731	67	9	29298432
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	USP36 HOXA13 ZNF148 PRPF3 RBBP6 ATAD2B KTN1 DACH1 ZCCHC7 NSD3	1.39e-05	954	67	10	36373674
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	USP36 PBRM1 ANK2 PRPF3 KTN1 EIF3A	1.42e-05	271	67	6	32433965
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	USP36 GTPBP4 ZNF148 PRPF3 SRPK2 ZCCHC7 MED12	1.42e-05	410	67	7	26949251
Pubmed	Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus.	PRPF3 EIF2B4 SRPK2 PYM1 LARP7	1.44e-05	159	67	5	34578187
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	FANCD2 USP36 GTPBP4 PBRM1 CSNK2A2 KTN1 EIF3A RPL14 PRC1 ANKHD1 TTC3 LARP7	1.59e-05	1425	67	12	30948266
Pubmed	FBXW7 modulates cellular stress response and metastatic potential through HSF1 post-translational modification.	MYO5A MYCBP2 MED12 CREB3L2	1.61e-05	78	67	4	25720964
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	GTPBP4 MYO9B CSNK2A2 KTN1 EIF2B4 SRPK2 RPL14 ANKHD1	2.02e-05	601	67	8	33658012
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	GTPBP4 PBRM1 ZNF148 CSNK2A2 ATAD2B CHD2 TIMELESS NSD3	2.19e-05	608	67	8	36089195
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	FAM193A MYCBP2 MYO9B EIF2B4 PYM1 TTC3 MED12	3.05e-05	462	67	7	31138677
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CEP350 PBRM1 MYCBP2 CSNK2A2 PRC1 MED12 LARP7 NSD3	3.34e-05	645	67	8	25281560
Pubmed	CK2-regulated schwannomin-interacting protein IQCJ-SCHIP-1 association with AnkG contributes to the maintenance of the axon initial segment.	ANK2 CSNK2A2	3.64e-05	5	67	2	25950943
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	ZNF148 MYO9B CSNK2A2 KTN1 PRC1 CREB3L2	3.67e-05	321	67	6	32098917
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	GTPBP4 SULF2 FAM193A RBBP6 CIR1 SRPK2 RPL14 ANKHD1	3.72e-05	655	67	8	35819319
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	CEP350 USP36 GTPBP4 PBRM1 SRPK2 RPL14 LARP7	4.04e-05	483	67	7	36912080
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	USP36 GTPBP4 PBRM1 CSNK2A2 DDX60L LARP7	4.42e-05	332	67	6	25693804
Pubmed	Mouse Dach2 mutants do not exhibit gross defects in eye development or brain function.	DACH2 DACH1	5.46e-05	6	67	2	16470613
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	USP36 GTPBP4 KTN1 EIF2B4 EIF3A RPL14 DDX60L ANKHD1	6.61e-05	711	67	8	33022573
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MYO5A PDRG1 MYCBP2 CSNK2A2 EIF2B4 SRPK2 PYM1 EIF3A RPL14 ANKHD1	6.68e-05	1149	67	10	35446349
Pubmed	The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.	GTPBP4 PRPF3 PYM1 PRC1 LARP7	6.79e-05	220	67	5	31822558
Pubmed	Associations of human erythrocyte band 4.2. Binding to ankyrin and to the cytoplasmic domain of band 3.	BLOC1S6 ANK2	7.63e-05	7	67	2	2968981
Pubmed	Regulator of G protein signaling 12 drives inflammatory arthritis by activating synovial fibroblasts through MYCBP2/KIF2A signaling.	MYCBP2 RBBP6	7.63e-05	7	67	2	36700049
Pubmed	Defining the membrane proteome of NK cells.	CEP350 GTPBP4 MYO5A MYCBP2 MYO9B KTN1 EIF3A RPL14 FKBP11 MED12	7.65e-05	1168	67	10	19946888
Pubmed	Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.	CEP350 GTPBP4 MYCBP2 CSNK2A2	7.66e-05	116	67	4	21282530
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	GTPBP4 PDRG1 PRPF3 CSNK2A2 KTN1 EIF2B4 SRPK2 PYM1 EIF3A RPL14 ANKHD1	7.69e-05	1415	67	11	28515276
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	GTPBP4 MYO9B EIF2B4 SRPK2 PYM1 ANKHD1 TTC3 LARP7	8.09e-05	732	67	8	34732716
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	HOXA13 ZNF148 DACH1 EIF3A ANKHD1	8.90e-05	233	67	5	37704626
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	FANCD2 GTPBP4 PRPF3 DDX60 CSNK2A2 KTN1 EIF2B4 EIF3A RPL14 DDX60L LARP7	8.99e-05	1440	67	11	30833792
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GTPBP4 PBRM1 ANK2 MYO5A MYCBP2 CSNK2A2 KTN1 SRPK2 TTC3	9.35e-05	963	67	9	28671696
Pubmed	Mouse Dach1 and Dach2 are redundantly required for Müllerian duct development.	DACH2 DACH1	1.02e-04	8	67	2	18395837
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	CEP350 MYCBP2 EIF2B4 ANKHD1 MED12	1.06e-04	242	67	5	34011540
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	FANCD2 PBRM1 PRPF3 PRC1 PDCD7 TCF7L1	1.17e-04	396	67	6	26687479
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MYO5A MYCBP2 PRPF3 EIF2B4 GPATCH2 SRPK2 CHD2 IGSF9B PRKRIP1 TTC3 CREB3L2	1.21e-04	1489	67	11	28611215
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	FANCD2 GTPBP4 MYCBP2 MTRFR KTN1 DACH1 SRPK2 GPAM PYM1 RPL14 TTC3	1.26e-04	1496	67	11	32877691
Pubmed	Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.	GTPBP4 PRPF3 CSNK2A2 SRPK2 LARP7	1.26e-04	251	67	5	28077445
Pubmed	Pleiotropic effects in Eya3 knockout mice.	DACH2 DACH1	1.30e-04	9	67	2	19102749
Pubmed	The fine structure of melanogenesis in coat color mutants of the mouse.	BLOC1S6 MYO5A	1.30e-04	9	67	2	4634048
Pubmed	Functional proteomics mapping of a human signaling pathway.	EVC2 PBRM1 MYCBP2 RBBP6 ZCCHC7 PDCD7 TTC3	1.42e-04	591	67	7	15231748
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CEP350 GTPBP4 PBRM1 MYO5A MYCBP2 PRPF3 MYO9B EIF3A RPL14	1.48e-04	1024	67	9	24711643
Pubmed	Variability of Gene Expression Identifies Transcriptional Regulators of Early Human Embryonic Development.	CEP350 BLOC1S6 RBBP6	1.58e-04	54	67	3	26288249
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	MYCBP2 KTN1 EIF2B4 PYM1 EIF3A RPL14 PRC1 LARP7	1.61e-04	809	67	8	32129710
Pubmed	Targeted disruption of mouse Dach1 results in postnatal lethality.	DACH2 DACH1	1.63e-04	10	67	2	12508235
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	USP36 GTPBP4 PBRM1 PRPF3 EIF3A RPL14 LARP7	1.64e-04	605	67	7	28977666
Pubmed	Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT).	FANCD2 PBRM1 CHD2	1.67e-04	55	67	3	27114453
Pubmed	rec-YnH enables simultaneous many-by-many detection of direct protein-protein and protein-RNA interactions.	MYO5A PRPF3 RBBP6 PRC1	1.67e-04	142	67	4	30217970
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	GTPBP4 MYCBP2 RBBP6 CSNK2A2 CIR1 SRPK2 EIF3A RPL14 ANKHD1 NSD3	1.80e-04	1297	67	10	33545068
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	PDRG1 KTN1 SRPK2 EIF3A RPL14 PRC1 LARP7	1.81e-04	615	67	7	31048545
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	GTPBP4 PRPF3 RBBP6 EIF3A LARP7	1.90e-04	274	67	5	34244482
Pubmed	ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.	GTPBP4 MYCBP2 EIF2B4 RPL14 ANKHD1 TTC3 MED12	1.98e-04	624	67	7	33729478
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	GTPBP4 PBRM1 ZNF148 RBBP6 CSNK2A2 EIF2B4 CHD2 EIF3A RPL14 LARP7	2.05e-04	1318	67	10	30463901
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	SLC43A2 AHI1 FMN1 CSNK2A2 PYM1 CHD2 TIMELESS ANKHD1 TTC3	2.27e-04	1084	67	9	11544199
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ZNF148 MYO9B KTN1 DACH1 SRPK2 PRC1 ANKHD1 LARP7	2.38e-04	857	67	8	25609649
Pubmed	Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer.	GTPBP4 EIF2B4 PRC1	2.50e-04	63	67	3	34718347
Pubmed	p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.	CEP350 MYO5A SRPK2 FKBP11	2.58e-04	159	67	4	30581152
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	HOXA13 ZNF148 MYCBP2 PRPF3 CSNK2A2 DACH1 PRKRIP1 PRC1 MED12	2.58e-04	1103	67	9	34189442
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	GTPBP4 PRPF3 RBBP6 SRPK2 PYM1 RPL14 LARP7	2.61e-04	653	67	7	33742100
Pubmed	Alternative exon skipping biases substrate preference of the deubiquitylase USP15 for mysterin/RNF213, the moyamoya disease susceptibility factor.	MYCBP2 PRPF3 LARP7	2.74e-04	65	67	3	28276505
Pubmed	A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.	FANCD2 PDRG1 KTN1 ANKHD1	2.77e-04	162	67	4	14743216
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	GTPBP4 MYO5A PRPF3 CSNK2A2 EIF3A PRC1 TFPI	2.79e-04	660	67	7	32780723
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	PBRM1 ZNF148 RBBP6 CSNK2A2 PYM1 CHD2	2.90e-04	469	67	6	27634302
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	PBRM1 FAM193A FMN1 IGSF9B RPL14 LARP7	3.10e-04	475	67	6	31040226
Pubmed	Distinct nuclear and cytoplasmic assemblies and interactomes of the mammalian CTLH E3 ligase complex.	GTPBP4 PRPF3 KTN1 RPL14	3.11e-04	167	67	4	35833506
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	GTPBP4 FAM193A PRPF3 RBBP6 SRPK2 PYM1 RPL14	3.28e-04	678	67	7	30209976
Pubmed	Gli3 (Xt) and formin (ld) participate in the positioning of the polarising region and control of posterior limb-bud identity.	HOXA13 FMN1	3.28e-04	14	67	2	9834182
Pubmed	Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.	MYO5A MYO9B	3.28e-04	14	67	2	8022818
Pubmed	Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.	FMN1 SRPK2	3.28e-04	14	67	2	8605874
Pubmed	A human MAP kinase interactome.	CEP350 BLOC1S6 RBBP6 KTN1 EIF3A NSD3	3.51e-04	486	67	6	20936779
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	GTPBP4 PBRM1 PRPF3 MYO9B EIF3A RPL14	3.51e-04	486	67	6	30940648
Pubmed	Interaction of the murine dilute suppressor gene (dsu) with fourteen coat color mutations.	BLOC1S6 MYO5A	3.78e-04	15	67	2	2379821
Pubmed	Human transcription factor protein interaction networks.	GTPBP4 PBRM1 ZNF148 MYO5A RBBP6 CSNK2A2 DACH1 EIF3A RPL14 ANKHD1	3.90e-04	1429	67	10	35140242
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	ANK2 MYCBP2 KTN1 CHD2 EIF3A TTC3	3.95e-04	497	67	6	23414517
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	AHI1 FAM193A MYO5A KTN1 RPL14 PRKRIP1 ANKHD1 TTC3	3.96e-04	925	67	8	28986522
Pubmed	A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities.	FANCD2 PRPF3 TIMELESS RPL14	4.12e-04	180	67	4	24104479
Interaction	RPS16 interactions	FANCD2 USP36 GTPBP4 PBRM1 PRPF3 CSNK2A2 KTN1 SRPK2 PYM1 EIF3A RPL14 PRC1 ANKHD1 LARP7	7.21e-08	724	66	14	int:RPS16
Interaction	RPS3A interactions	FANCD2 GTPBP4 PDRG1 PRPF3 CSNK2A2 SRPK2 PYM1 EIF3A RPL14 PRC1 ANKHD1 MED12 LARP7	1.68e-07	655	66	13	int:RPS3A
Interaction	BOP1 interactions	FANCD2 USP36 AHI1 CSNK2A2 MTRFR SRPK2 RPL14 PRC1	2.02e-07	191	66	8	int:BOP1
Interaction	COIL interactions	USP36 GTPBP4 HOXA13 PBRM1 ZNF148 PRPF3 CSNK2A2 MTRFR DACH1 SRPK2 LARP7 NSD3	2.03e-07	552	66	12	int:COIL
Interaction	PPAN interactions	FANCD2 USP36 GTPBP4 CSNK2A2 SRPK2 ZCCHC7 PRC1 LARP7	2.19e-07	193	66	8	int:PPAN
Interaction	SSRP1 interactions	FANCD2 USP36 PBRM1 PRPF3 RBBP6 CSNK2A2 MTRFR CHD2 TIMELESS EIF3A RPL14 PRC1 LARP7	2.81e-07	685	66	13	int:SSRP1
Interaction	HECTD1 interactions	GTPBP4 PBRM1 MYO5A MYCBP2 PRPF3 MYO9B RBBP6 KTN1 EIF2B4 SRPK2 RPL14 PRC1 PDCD7 MED12 LARP7	4.97e-07	984	66	15	int:HECTD1
Interaction	BRD3 interactions	GTPBP4 PBRM1 ZNF148 PRPF3 MYO9B RBBP6 CSNK2A2 DACH1 SRPK2 LARP7 NSD3	5.47e-07	494	66	11	int:BRD3
Interaction	ATG16L1 interactions	CEP350 FAM193A MYO5A MYCBP2 TTLL6 RBBP6 CSNK2A2 KTN1 EIF2B4 CIR1 SRPK2 PYM1 EIF3A PRC1 PDCD7 MEFV	7.38e-07	1161	66	16	int:ATG16L1
Interaction	NUP43 interactions	FANCD2 USP36 PBRM1 RBBP6 DDX60 ATAD2B TIMELESS ZCCHC7 PRC1 MED12 LARP7 NSD3	7.59e-07	625	66	12	int:NUP43
Interaction	RRP15 interactions	FANCD2 USP36 CSNK2A2 SRPK2 RPL14 PRC1 LARP7	8.07e-07	157	66	7	int:RRP15
Interaction	ZCCHC10 interactions	SULF2 MYO5A PRPF3 MYO9B RBBP6 DACH1 DDX60L TTC3	1.01e-06	236	66	8	int:ZCCHC10
Interaction	CGAS interactions	MYO5A MYCBP2 DDX60 ATAD2B KTN1 CHD2 DDX60L PRC1 LARP7	1.21e-06	329	66	9	int:CGAS
Interaction	FBXW7 interactions	FANCD2 USP36 GTPBP4 MYO5A MYCBP2 MYO9B CSNK2A2 KTN1 EIF2B4 SRPK2 EIF3A RPL14 PRC1 ANKHD1 MED12 CREB3L2	1.35e-06	1215	66	16	int:FBXW7
Interaction	THRAP3 interactions	FANCD2 MYCBP2 PRPF3 RBBP6 CSNK2A2 SRPK2 PYM1 PRC1 MED12 LARP7	1.67e-06	443	66	10	int:THRAP3
Interaction	PUM3 interactions	FANCD2 USP36 GTPBP4 SRPK2 RPL14 ZCCHC7 PRC1 LARP7	1.74e-06	254	66	8	int:PUM3
Interaction	RPS10 interactions	FANCD2 USP36 GTPBP4 PRPF3 CSNK2A2 SRPK2 PYM1 EIF3A RPL14 PRC1 LARP7	2.10e-06	567	66	11	int:RPS10
Interaction	CASQ2 interactions	SULF2 MYO5A MYCBP2 PRPF3 CSNK2A2	2.67e-06	67	66	5	int:CASQ2
Interaction	LYAR interactions	FANCD2 USP36 GTPBP4 AHI1 CSNK2A2 SRPK2 EIF3A PRC1 LARP7	3.38e-06	373	66	9	int:LYAR
Interaction	PFN1 interactions	CEP350 FANCD2 USP36 ANK2 MYO5A MYO9B KTN1 SRPK2 ANKHD1 LARP7	5.74e-06	509	66	10	int:PFN1
Interaction	NPM1 interactions	FANCD2 USP36 GTPBP4 PBRM1 MYO5A MYO9B CSNK2A2 KTN1 EIF2B4 SRPK2 EIF3A RPL14 ZCCHC7 PRC1 LARP7	5.88e-06	1201	66	15	int:NPM1
Interaction	TOP2A interactions	FANCD2 USP36 PBRM1 CSNK2A2 MTRFR KTN1 SRPK2 EIF3A RPL14 PRC1	6.92e-06	520	66	10	int:TOP2A
Interaction	RPL11 interactions	FANCD2 USP36 GTPBP4 PBRM1 KTN1 SRPK2 EIF3A RPL14 ZCCHC7 PRC1 LARP7	7.96e-06	652	66	11	int:RPL11
Interaction	RPLP1 interactions	FANCD2 USP36 CSNK2A2 EIF3A RPL14 PRC1 ANKHD1 LARP7	8.72e-06	316	66	8	int:RPLP1
Interaction	FTSJ3 interactions	FANCD2 USP36 ANK2 EIF2B4 SRPK2 RPL14 ZCCHC7 PRC1 LARP7	9.15e-06	422	66	9	int:FTSJ3
Interaction	PCBP1 interactions	FANCD2 USP36 PRPF3 MYO9B RBBP6 CSNK2A2 SRPK2 EIF3A RPL14 PRC1 LARP7	1.04e-05	671	66	11	int:PCBP1
Interaction	BRD2 interactions	GTPBP4 SULF2 PBRM1 PRPF3 CSNK2A2 TAF7L PRC1 LARP7 NSD3	1.04e-05	429	66	9	int:BRD2
Interaction	EBNA1BP2 interactions	FANCD2 USP36 GTPBP4 EIF2B4 SRPK2 RPL14 PRC1 LARP7	1.05e-05	324	66	8	int:EBNA1BP2
Interaction	NOLC1 interactions	FANCD2 USP36 DDX60 CSNK2A2 SRPK2 PRC1 MED12 LARP7	1.07e-05	325	66	8	int:NOLC1
Interaction	PPM1G interactions	FANCD2 USP36 MYO9B CSNK2A2 DACH1 SRPK2 EIF3A LARP7	1.07e-05	325	66	8	int:PPM1G
Interaction	NIFK interactions	FANCD2 USP36 GTPBP4 RBBP6 CSNK2A2 SRPK2 RPL14 PRC1 LARP7	1.08e-05	431	66	9	int:NIFK
Interaction	APEX1 interactions	USP36 GTPBP4 AHI1 PBRM1 FAM193A ZNF148 MYO5A KTN1 DACH1 SRPK2 RPL14 PRKRIP1 ANKHD1 TTC3 NSD3	1.16e-05	1271	66	15	int:APEX1
Interaction	DDX27 interactions	FANCD2 USP36 GTPBP4 RBBP6 SRPK2 RPL14 PRC1 MED12	1.17e-05	329	66	8	int:DDX27
Interaction	RPF2 interactions	FANCD2 USP36 GTPBP4 MTRFR SRPK2 RPL14 PRC1	1.20e-05	236	66	7	int:RPF2
Interaction	SRP72 interactions	USP36 GTPBP4 AHI1 KTN1 SRPK2 EIF3A RPL14 LARP7	1.28e-05	333	66	8	int:SRP72
Interaction	RPL22 interactions	FANCD2 USP36 GTPBP4 PRPF3 CSNK2A2 SRPK2 RPL14 PRC1 LARP7	1.28e-05	440	66	9	int:RPL22
Interaction	RPS26 interactions	FANCD2 USP36 SRPK2 PYM1 EIF3A RPL14 PRC1 LARP7	1.30e-05	334	66	8	int:RPS26
Interaction	EIF3B interactions	CEP350 FANCD2 DDX60 CSNK2A2 KTN1 EIF3A RPL14 LARP7	1.39e-05	337	66	8	int:EIF3B
Interaction	MAK16 interactions	FANCD2 USP36 GTPBP4 CSNK2A2 SRPK2 RPL14	1.50e-05	162	66	6	int:MAK16
Interaction	WDR12 interactions	FANCD2 USP36 GTPBP4 CSNK2A2 SRPK2 PRC1	1.50e-05	162	66	6	int:WDR12
Interaction	CAPRIN1 interactions	USP36 MYCBP2 KTN1 PYM1 EIF3A RPL14 PRC1 MED12 LARP7	1.55e-05	451	66	9	int:CAPRIN1
Interaction	AKAP17A interactions	CSNK2A2 KTN1 SRPK2 ANKHD1 TTC3	1.82e-05	99	66	5	int:AKAP17A
Interaction	CTCF interactions	FANCD2 USP36 GTPBP4 KTN1 SRPK2 EIF3A RPL14 PRC1 LARP7	1.85e-05	461	66	9	int:CTCF
Interaction	SRPK2 interactions	USP36 GTPBP4 MYCBP2 RBBP6 TAF7L C16orf78 SRPK2 CHD2 EIF3A RPL14 LARP7	1.93e-05	717	66	11	int:SRPK2
Interaction	DDX21 interactions	FANCD2 USP36 GTPBP4 PRPF3 SRPK2 CHD2 EIF3A RPL14 PRC1 MED12 LARP7	1.96e-05	718	66	11	int:DDX21
Interaction	PES1 interactions	FANCD2 USP36 GTPBP4 CSNK2A2 SRPK2 PRC1 LARP7	2.13e-05	258	66	7	int:PES1
Interaction	RBM8A interactions	FANCD2 GTPBP4 KTN1 SRPK2 PYM1 EIF3A RPL14 PRC1 LARP7	2.26e-05	473	66	9	int:RBM8A
Interaction	ZCCHC17 interactions	USP36 CSNK2A2 KTN1 SRPK2 EIF3A	2.31e-05	104	66	5	int:ZCCHC17
Interaction	DDX54 interactions	FANCD2 USP36 CSNK2A2 MTRFR SRPK2 RPL14 PRC1 LARP7	2.32e-05	362	66	8	int:DDX54
Interaction	MEN1 interactions	FANCD2 GTPBP4 PBRM1 ZNF148 PRPF3 RBBP6 CSNK2A2 KTN1 SRPK2 EIF3A RPL14 MED12 NSD3	2.44e-05	1029	66	13	int:MEN1
Interaction	DDX23 interactions	FANCD2 USP36 GTPBP4 PRPF3 RBBP6 SRPK2 CHD2 PRC1 LARP7	2.54e-05	480	66	9	int:DDX23
Interaction	RBM28 interactions	FANCD2 USP36 GTPBP4 MTRFR SRPK2 RPL14 PRC1 LARP7	2.61e-05	368	66	8	int:RBM28
Interaction	SIRT7 interactions	GTPBP4 PBRM1 MYO5A MYCBP2 CSNK2A2 ATAD2B CHD2 RPL14 ANKHD1 MED12 LARP7	2.72e-05	744	66	11	int:SIRT7
Interaction	POLR1G interactions	USP36 GTPBP4 PBRM1 PDRG1 CSNK2A2 DACH1 CHD2 LARP7 NSD3	2.94e-05	489	66	9	int:POLR1G
Interaction	RPL10A interactions	FANCD2 USP36 GTPBP4 PBRM1 SRPK2 RPL14 ZCCHC7 PRC1 LARP7	2.98e-05	490	66	9	int:RPL10A
Interaction	PIWIL2 interactions	FANCD2 CSNK2A2 PRC1	3.13e-05	19	66	3	int:PIWIL2
Interaction	EPB42 interactions	FANCD2 ANK2 LARP7	3.13e-05	19	66	3	int:EPB42
Interaction	DDX47 interactions	FANCD2 USP36 GTPBP4 DDX60 SRPK2 PRC1	3.27e-05	186	66	6	int:DDX47
Interaction	SNRPD3 interactions	FANCD2 PRPF3 KTN1 RPL14 PRKRIP1 PRC1 PDCD7 LARP7	3.28e-05	380	66	8	int:SNRPD3
Interaction	POP1 interactions	FANCD2 USP36 GTPBP4 CSNK2A2 SRPK2 PRC1 LARP7	3.35e-05	277	66	7	int:POP1
Interaction	EIF4A3 interactions	FANCD2 PRPF3 RBBP6 DACH1 SRPK2 PYM1 PRC1 ANKHD1 LARP7	3.44e-05	499	66	9	int:EIF4A3
Interaction	SIRT6 interactions	GTPBP4 PBRM1 MYCBP2 PRPF3 CSNK2A2 GPATCH2 SRPK2 PRC1 MED12 LARP7	3.52e-05	628	66	10	int:SIRT6
Interaction	PELP1 interactions	FANCD2 USP36 ZNF148 MYCBP2 CSNK2A2 SRPK2	3.58e-05	189	66	6	int:PELP1
Interaction	CEBPZ interactions	FANCD2 USP36 GTPBP4 SRPK2 RPL14 PRC1 LARP7	3.67e-05	281	66	7	int:CEBPZ
Interaction	SNRNP40 interactions	USP36 PRPF3 RBBP6 ATAD2B SRPK2 ZCCHC7 PRC1 MED12 LARP7 NSD3	3.97e-05	637	66	10	int:SNRNP40
Interaction	PRPF8 interactions	FANCD2 USP36 PDRG1 PRPF3 RBBP6 SRPK2 EIF3A RPL14 PRC1 MED12 LARP7	3.99e-05	776	66	11	int:PRPF8
Interaction	RPL34 interactions	FANCD2 USP36 CSNK2A2 SRPK2 RPL14 PRC1 LARP7	4.01e-05	285	66	7	int:RPL34
Interaction	DKC1 interactions	FANCD2 USP36 GTPBP4 SRPK2 EIF3A RPL14 PRC1 LARP7	4.17e-05	393	66	8	int:DKC1
Interaction	MKI67 interactions	FANCD2 USP36 GTPBP4 ZNF148 PRPF3 CSNK2A2 SRPK2 ZCCHC7 PRC1 MED12	4.58e-05	648	66	10	int:MKI67
Interaction	CHD4 interactions	FANCD2 USP36 GTPBP4 PBRM1 PRPF3 RBBP6 CSNK2A2 EIF3A RPL14 PRC1 ANKHD1 LARP7	4.65e-05	938	66	12	int:CHD4
Interaction	RIOX1 interactions	FANCD2 MYO9B RPL14 LARP7	4.76e-05	61	66	4	int:RIOX1
Interaction	RPL7L1 interactions	FANCD2 USP36 GTPBP4 CSNK2A2 RPL14 PRC1	5.33e-05	203	66	6	int:RPL7L1
Interaction	EFTUD2 interactions	FANCD2 GTPBP4 PDRG1 PRPF3 CSNK2A2 KTN1 EIF2B4 SRPK2 PYM1 EIF3A RPL14 PRC1 ANKHD1 MED12 LARP7	5.38e-05	1449	66	15	int:EFTUD2
Interaction	RPL10L interactions	FANCD2 USP36 RPL14 PRC1 LARP7	5.38e-05	124	66	5	int:RPL10L
Interaction	BRIX1 interactions	FANCD2 USP36 GTPBP4 SRPK2 RPL14 PRC1 LARP7	5.55e-05	300	66	7	int:BRIX1
Interaction	DOT1L interactions	GTPBP4 PBRM1 ZNF148 PRPF3 RBBP6 CSNK2A2 KTN1 SRPK2 EIF3A LARP7 NSD3	5.69e-05	807	66	11	int:DOT1L
Interaction	RPL3L interactions	CSNK2A2 RPL14 PRC1 LARP7	5.75e-05	64	66	4	int:RPL3L
Interaction	PPIG interactions	RBBP6 DACH1 SRPK2 EIF3A RPL14	6.03e-05	127	66	5	int:PPIG
Interaction	SON interactions	FANCD2 PRPF3 RBBP6 SRPK2 PRC1 TFPI	6.10e-05	208	66	6	int:SON
Interaction	RPS18 interactions	FANCD2 USP36 CSNK2A2 PYM1 EIF3A RPL14 PRC1 LARP7	6.11e-05	415	66	8	int:RPS18
Interaction	EIF2S3 interactions	USP36 DDX60 KTN1 EIF2B4 PYM1 EIF3A RPL14	6.16e-05	305	66	7	int:EIF2S3
Interaction	SNRPE interactions	FANCD2 PRPF3 SRPK2 PRKRIP1 PRC1 PDCD7 LARP7	6.16e-05	305	66	7	int:SNRPE
Interaction	NOP2 interactions	FANCD2 USP36 GTPBP4 CSNK2A2 MTRFR SRPK2 RPL14 PRC1	6.21e-05	416	66	8	int:NOP2
Interaction	ETV3 interactions	GTPBP4 PBRM1 ZNF148 DACH1 NSD3	6.26e-05	128	66	5	int:ETV3
Interaction	NOP58 interactions	FANCD2 USP36 GTPBP4 PRPF3 PRC1 MED12 LARP7	6.68e-05	309	66	7	int:NOP58
Interaction	EIF3J interactions	FANCD2 DDX60 CSNK2A2 EIF3A PDCD7	6.74e-05	130	66	5	int:EIF3J
Interaction	NAA40 interactions	USP36 GTPBP4 FAM193A ZNF148 ANK2 PRPF3 RBBP6 KTN1 PYM1 EIF3A RPL14 ANKHD1	6.95e-05	978	66	12	int:NAA40
Interaction	SRSF7 interactions	FANCD2 PRPF3 RBBP6 SRPK2 PRKRIP1 PRC1 LARP7 TFPI	7.22e-05	425	66	8	int:SRSF7
Interaction	MCC interactions	CEP350 BLOC1S6 MYO9B DACH1 EIF3A CCDC180	7.33e-05	215	66	6	int:MCC
Interaction	RRP1B interactions	USP36 GTPBP4 CSNK2A2 SRPK2 RPL14 PRC1 LARP7	7.39e-05	314	66	7	int:RRP1B
Interaction	WDR18 interactions	FANCD2 ZNF148 MYCBP2 DDX60 CSNK2A2	7.51e-05	133	66	5	int:WDR18
Interaction	TOP1 interactions	FANCD2 USP36 PBRM1 PRPF3 RBBP6 CSNK2A2 SRPK2 EIF3A PRC1 LARP7	8.32e-05	696	66	10	int:TOP1
Interaction	RPS12 interactions	FANCD2 CSNK2A2 PYM1 EIF3A RPL14 PRC1 LARP7	8.48e-05	321	66	7	int:RPS12
Interaction	IMP3 interactions	FANCD2 USP36 GTPBP4 RPL14 PRC1	8.64e-05	137	66	5	int:IMP3
Interaction	RPL10 interactions	FANCD2 USP36 GTPBP4 PDRG1 EIF2B4 EIF3A RPL14 PRC1 PDCD7 LARP7	8.93e-05	702	66	10	int:RPL10
Interaction	RACK1 interactions	FANCD2 GTPBP4 MYCBP2 PRPF3 CSNK2A2 KTN1 SRPK2 EIF3A RPL14 PRC1	9.14e-05	704	66	10	int:RACK1
Interaction	NOP56 interactions	FANCD2 USP36 GTPBP4 PRPF3 EIF2B4 SRPK2 RPL14 PRC1 LARP7	9.58e-05	570	66	9	int:NOP56
Interaction	GTPBP4 interactions	FANCD2 USP36 GTPBP4 CSNK2A2 SRPK2 RPL14 PRC1 LARP7	9.63e-05	443	66	8	int:GTPBP4
Interaction	PRPF40A interactions	FANCD2 PRPF3 FMN1 CSNK2A2 SRPK2 PRC1 PDCD7 LARP7	1.01e-04	446	66	8	int:PRPF40A
Interaction	IFI16 interactions	USP36 GTPBP4 PBRM1 ZNF148 PRPF3 CSNK2A2 KTN1 EIF3A DDX60L LARP7	1.03e-04	714	66	10	int:IFI16
Cytoband	13q22	MYCBP2 DACH1	1.14e-04	11	67	2	13q22
Cytoband	4q32.3	DDX60 DDX60L	1.14e-03	34	67	2	4q32.3
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	CEP350 AHI1 SULF2 PBRM1 ZNF148 MYO5A MYCBP2 KTN1 EIF3A ANKHD1 LARP7	8.00e-07	656	67	11	M18979
Coexpression	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	CEP350 PBRM1 RBBP6 CSNK2A2 KTN1 SRPK2 CHD2 LARP7	6.65e-06	389	67	8	M6520
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CEP350 FAM193A ZNF148 MYCBP2 MYO9B ATAD2B SRPK2 EIF3A TFPI CREB3L2	6.02e-05	856	67	10	M4500
Coexpression	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN	PBRM1 PRPF3 RBBP6 PRC1 TTC3	6.56e-05	165	67	5	M8121
Coexpression	JOHNSTONE_PARVB_TARGETS_3_DN	CEP350 FANCD2 GTPBP4 MYO5A MTRFR KTN1 SMIM15 ZCCHC7 PRC1 NSD3	7.36e-05	877	67	10	M2241
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	SLC43A2 FSIP1 FMN1 SRPK2 CHD2 PRKRIP1 CCDC191	9.38e-05	417	67	7	M39224
Coexpression	GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN	CEP350 ZNF148 MYCBP2 SNX29P2 ATAD2B	1.40e-04	194	67	5	M7306
Coexpression	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN	CEP350 PDRG1 RBBP6 MTRFR CHD2	1.44e-04	195	67	5	M9808
Coexpression	GSE45365_WT_VS_IFNAR_KO_CD11B_DC_UP	USP36 SULF2 MTRFR CCDC180 NSD3	1.47e-04	196	67	5	M9971
Coexpression	GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN	REXO2 SULF2 DDX60 RPL14 TTC3	1.51e-04	197	67	5	M8227
Coexpression	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP	AHI1 MYCBP2 DDX60 GPATCH2 CHD2	1.54e-04	198	67	5	M6025
Coexpression	GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN	FANCD2 SULF2 MYO5A GPAM PDCD7	1.58e-04	199	67	5	M7099
Coexpression	GSE3982_MAC_VS_TH1_DN	USP36 TIMELESS IGSF9B PRC1 ANKHD1	1.58e-04	199	67	5	M5511
Coexpression	GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN	REXO2 MYO5A MYO9B DDX60 TTC3	1.58e-04	199	67	5	M8770
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	GTPBP4 AHI1 FAM193A MYO5A RBBP6 ATAD2B CHD2 EIF3A SMIM15 ANKHD1	4.02e-08	311	66	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	GTPBP4 AHI1 FAM193A MYO5A RBBP6 KTN1 DACH1 SRPK2 CHD2 EIF3A SMIM15 ANKHD1	8.39e-06	831	66	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	GTPBP4 AHI1 FAM193A MYO5A RBBP6 ATAD2B KTN1 DACH1 CHD2 EIF3A SMIM15 ANKHD1	4.69e-05	989	66	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	CEP350 FANCD2 AHI1 FAM193A ANK2 MYO5A RBBP6 ATAD2B KTN1 EIF3A SMIM15 TCF7L1 LARP7	1.11e-04	1257	66	13	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	CEP350 FANCD2 AHI1 FAM193A ANK2 MYO5A RBBP6 ATAD2B KTN1 DACH1 EIF3A SMIM15 TCF7L1 LARP7	1.29e-04	1459	66	14	facebase_RNAseq_e10.5_Emin_LatNas_2500
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	CEP350 AHI1 RBBP6 CIR1 CHD2 EIF3A LARP7	1.93e-08	197	67	7	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	CEP350 REXO2 RBBP6 KTN1 SRPK2 TTC3 LARP7	2.07e-08	199	67	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	REXO2 RBBP6 KTN1 SRPK2 TTC3 LARP7 NSD3	2.07e-08	199	67	7	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CEP350 MYCBP2 DDX60 ATAD2B CHD2 EIF3A DDX60L	2.14e-08	200	67	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	CEP350 AHI1 PBRM1 RBBP6 KTN1 TTC3	5.06e-07	196	67	6	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	CEP350 REXO2 MYCBP2 RBBP6 SRPK2 TTC3	5.37e-07	198	67	6	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	CEP350 REXO2 RBBP6 KTN1 SRPK2 TTC3	5.54e-07	199	67	6	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 KTN1 CHD2 RPL14 ZCCHC7	8.08e-06	182	67	5	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 KTN1 CHD2 RPL14 ZCCHC7	8.30e-06	183	67	5	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	CEP350 RBBP6 DDX60 CHD2 DDX60L	8.30e-06	183	67	5	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 KTN1 CHD2 RPL14 ZCCHC7	8.30e-06	183	67	5	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEP350 MYCBP2 KTN1 EIF3A ZCCHC7	8.52e-06	184	67	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	USP36 DDX60 CIR1 DDX60L NSD3	1.07e-05	193	67	5	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	Mild/Remission\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DDX60 CIR1 RPL14 DDX60L NSD3	1.16e-05	196	67	5	71603a3b7df40eb3f267345f55e44a812fea7926
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	CEP350 KTN1 TTC3 LARP7 NSD3	1.24e-05	199	67	5	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CCL\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC43A2 SULF2 PDRG1 MYO9B MEFV	1.24e-05	199	67	5	51be0e3a91d1f25454b56d55ef6342ef8e8df4e8
ToppCell	ASK454-Epithelial-Secretory\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	EVC2 FSIP1 CSNK2A2 MEFV	6.60e-05	144	67	4	8e693b50bd6c69ce68f44ca6e51f6d0c7f80d82c
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SULF2 MYO9B TAF7L CHD2	8.77e-05	155	67	4	77ae0b8d30bc3db4a73fd5340f99691a73d2684f
ToppCell	droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REXO2 EVC2 FKBP11 CREB3L2	1.12e-04	165	67	4	21a82a975f550080b6674750b06212205cd16742
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FANCD2 DDX60 DACH1 SEL1L2	1.20e-04	168	67	4	55c9de7b3a1d6cf7b02b020ff92ab4ede8d195cc
ToppCell	facs-Marrow-KLS-3m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REXO2 IGSF9B FKBP11 CREB3L2	1.22e-04	169	67	4	b798b91567d2f49082e2d8a337169f241c8d2080
ToppCell	facs-Marrow-T_cells-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REXO2 FMN1 FKBP11 CREB3L2	1.34e-04	173	67	4	e0cf99ddbe6e9eab05d7bf89e9aa124850c6a807
ToppCell	facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REXO2 EVC2 FKBP11 CREB3L2	1.43e-04	176	67	4	5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45
ToppCell	facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REXO2 EVC2 FKBP11 CREB3L2	1.46e-04	177	67	4	35d42b07d9c31528bf59199e361bb8a3bfbe3b75
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	REXO2 TAF7L EIF3A NSD3	1.66e-04	183	67	4	317b756378a9efd8ecb754acf7273f83f996e106
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REXO2 EVC2 FKBP11 CREB3L2	1.70e-04	184	67	4	1da7936a2616986efd5de601ad525f1f2355128a
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REXO2 EVC2 FKBP11 CREB3L2	1.73e-04	185	67	4	238938a4682b44e88a30b86b13af4feeabe9553d
ToppCell	Mild/Remission-B_activate-7\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DDX60 DDX60L ZCCHC7 NSD3	1.96e-04	191	67	4	382686d62f7b8576c44bb9726a4e10dc26fd348e
ToppCell	ASK454-Epithelial-Secretory\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	EVC2 FSIP1 CSNK2A2 MEFV	1.96e-04	191	67	4	c63c781e7e93265e591cf494cb4ce8ed797c24fb
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	USP36 DDX60 RPL14 TTC3	2.00e-04	192	67	4	35557254738844c27ffcd00f3287fbcc0a4d0f3b
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175\|Adult / Lineage, Cell type, age group and donor	MYO5A MYO9B FMN1 DDX60L	2.00e-04	192	67	4	733491e932350e3c216a626cc49c3cd3fe970a82
ToppCell	Control-Myeloid-cMonocyte\|Control / Disease state, Lineage and Cell class	SLC43A2 SULF2 MYO9B MEFV	2.00e-04	192	67	4	ad04c9c4bdebf94615cee1904ca48197e62c923b
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH2 DACH1 SRPK2 TCF7L1	2.04e-04	193	67	4	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	RA-08._Macrophage\|World / Chamber and Cluster_Paper	SLC43A2 MYO5A MYO9B FMN1	2.04e-04	193	67	4	5fd22db1825d105709fcc0aa4955c99a117e3c82
ToppCell	Control-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	SLC43A2 SULF2 MYO9B MEFV	2.08e-04	194	67	4	f852f5258617a66a4fbd56d64c7b47272e7b8b60
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231\|Adult / Lineage, Cell type, age group and donor	SLC43A2 MYO5A MYO9B FMN1	2.08e-04	194	67	4	800d3d7a9e864d2d6a100a4e4af22f45d5790a8d
ToppCell	Mild/Remission-B_activate-7\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MYCBP2 DDX60 DDX60L ZCCHC7	2.08e-04	194	67	4	01c97543972159a9468272da06e7e611e2c21fae
ToppCell	Control-Myeloid-ncMonocyte\|Control / Disease state, Lineage and Cell class	SLC43A2 SULF2 MYO9B MEFV	2.12e-04	195	67	4	fcb05948e7480dc53f06f3fc9b9c3fc129874edd
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC43A2 MYCBP2 ZCCHC7 TTC3	2.12e-04	195	67	4	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	CV-Moderate-6\|Moderate / Virus stimulation, Condition and Cluster	CEP350 PBRM1 RBBP6 KTN1	2.12e-04	195	67	4	2b8a72d7e755b9655c7a496000d10ff06e50862b
ToppCell	Control-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	SLC43A2 SULF2 MYO9B MEFV	2.12e-04	195	67	4	b4444b67a709e82b8e2ee510924c3152cb88b051
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	FANCD2 DACH1 TIMELESS PRC1	2.16e-04	196	67	4	5905f0e3061a6b98b7a33d64c782c3dda2cd51ef
ToppCell	Severe-Lymphoid-T-CCR7+_T\|Severe / Condition, Lineage, Cell class and cell subclass	REXO2 RPL14 FKBP11 NSD3	2.20e-04	197	67	4	0489e0b08f3c3ef90b166ea2f26a0b2b12bd2077
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TTLL6 FSIP1 CCDC180 CCDC191	2.20e-04	197	67	4	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SLC43A2 SULF2 FMN1 MEFV	2.20e-04	197	67	4	8b9a88fb671d5c2b25d291c851e2b8a478f2610c
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	DDX60 CIR1 DDX60L NSD3	2.20e-04	197	67	4	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	USP36 SULF2 MYO9B MEFV	2.20e-04	197	67	4	4a6eff66a17c5e89bda61d887b736f5c62b93bd7
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D231\|Adult / Lineage, Cell type, age group and donor	USP36 SLC43A2 MYO9B DDX60L	2.25e-04	198	67	4	79a415e19cedde13a88f5043d71557363f102322
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO9B FMN1 DDX60L MEFV	2.25e-04	198	67	4	ea34096bee852a7e996f097fa279381afa8f86ff
ToppCell	COVID-19-Myeloid\|COVID-19 / group, cell type (main and fine annotations)	SLC43A2 MYO5A MYO9B FMN1	2.25e-04	198	67	4	33f0a919188a67d2a876b52c61a1cec2c9747969
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	DDX60 CIR1 DDX60L NSD3	2.25e-04	198	67	4	44417089b62056269cac38d3134ff209c05b7007
ToppCell	Adult-Immune\|Adult / Lineage, Cell type, age group and donor	SLC43A2 MYO5A MYO9B DDX60L	2.25e-04	198	67	4	9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDX60 CIR1 DDX60L NSD3	2.25e-04	198	67	4	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil\|COVID-19_Mild / Disease, condition lineage and cell class	FANCD2 DACH1 PRC1 TCF7L1	2.29e-04	199	67	4	e222b90caf45904d8f763574e7b6aac13333df92
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	REXO2 KTN1 TTC3 LARP7	2.29e-04	199	67	4	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	RBBP6 TIMELESS PRC1 ANKHD1	2.29e-04	199	67	4	fd1d1b95e01719e3d0a17d9d1f29717a47209d32
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	REXO2 KTN1 SRPK2 TTC3	2.29e-04	199	67	4	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M\|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.	MYCBP2 CSNK2A2 TTC3 TFPI	2.29e-04	199	67	4	b2d7dea11207cca63d688f8051143850b29dbdf0
ToppCell	VE-CD4-antiviral_CD4\|VE / Condition, Cell_class and T cell subcluster	DDX60 RPL14 DDX60L FKBP11	2.29e-04	199	67	4	056a0538ca5e825ae6195b4c76c208708a014533
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|megakaryocytic / Lineage and Cell class	MYCBP2 KTN1 EIF3A TTC3	2.29e-04	199	67	4	99a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	RBBP6 TIMELESS PRC1 ANKHD1	2.29e-04	199	67	4	91882af9dc7265c9b419f4415cbcf656087a2ab3
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	FANCD2 RBBP6 TIMELESS PRC1	2.33e-04	200	67	4	d933978b55fefe52cad599b36f6b47a0c7f71f96
ToppCell	Striatum-Neuronal\|Striatum / BrainAtlas - Mouse McCarroll V32	MYO5A MYCBP2 SRPK2 TTC3	2.33e-04	200	67	4	c888fd487990cad482a4ca47601cdebc0ca3f3ce
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Monocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC43A2 SULF2 MYO9B MEFV	2.33e-04	200	67	4	fd72fe6565e2f4885481991492d58c323ab1ad40
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	FANCD2 RBBP6 TIMELESS PRC1	2.33e-04	200	67	4	3d932765c31aef1f80a118d51e8e66c50a758dbb
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC43A2 SULF2 MYO9B MEFV	2.33e-04	200	67	4	5432bdf495431cd26f6e4cd585100f3652588913
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate\|2m / Sample Type, Dataset, Time_group, and Cell type.	ZNF148 MYO5A TTC3 NSD3	2.33e-04	200	67	4	2a635694844ddabcd98462c5636a6f41a3f08a46
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC43A2 SULF2 MYO9B MEFV	2.33e-04	200	67	4	b4277b6faa69f20974696c7c422311f5c89e3663
Disease	chronotype measurement	FAM193A ANK2 MYCBP2 PRPF3 RBBP6 ATAD2B C16orf78 CIR1 ZCCHC7 PRKRIP1	1.90e-05	882	64	10	EFO_0008328
Disease	Malignant neoplasm of breast	SULF2 PBRM1 ANK2 KTN1 TIMELESS PRC1 TTC3 TCF7L1 MED12	4.94e-04	1074	64	9	C0006142
Disease	pulse pressure measurement	USP36 PBRM1 FAM193A ANK2 TTLL6 ATAD2B CHD2 TCF7L1 NSD3 CREB3L2	7.83e-04	1392	64	10	EFO_0005763
Disease	uric acid measurement	FSIP1 FMN1 GPATCH2 DACH1 CHD2 NSD3	2.07e-03	610	64	6	EFO_0004761
Disease	Polydactyly	HOXA13 AHI1 EVC2	2.12e-03	117	64	3	C0152427
Disease	response to simvastatin, myopathy	EVC2 C16orf78	3.60e-03	41	64	2	EFO_0004145, GO_1903491

Protein segments in the cluster

Peptide	Gene	Start	Entry
AKEIKRKIRKKLKEQ	AHI1	201	Q8N157
RQLAKQIREKKKLKI	GTPBP4	481	Q9BZE4
TEQKKIIKKRENKKR	C1orf131	46	Q8NDD1
KQKPKVVTVLKRNKK	C16orf78	51	Q8WTQ4
VVTVLKRNKKKEEKK	C16orf78	56	Q8WTQ4
QKRVKKLRKKQGSKE	CCDC180	661	Q9P1Z9
AIVQKRLKKEKKAKR	DACH1	676	Q9UI36
QKRLKKEKKTKRKLQ	DACH2	516	Q96NX9
ELQKLRAVKKKKKER	FAM193A	926	P78312
KEIEKLRKQLKVKVN	PDRG1	86	Q9NUG6
KNKVKKIIKLLDGKR	FMN1	1041	Q68DA7
KKPVRRKLKEKQKQK	ANK2	1701	Q01484
KRKSKKNIRKQRMKI	PBRM1	511	Q86U86
QGEKKKKKRDRQIQK	SLC43A2	406	Q8N370
KGIIKKRKVNNLKKD	ATAD2B	1146	Q9ULI0
NKLRKVKKSIEKQKI	DDX60	1171	Q8IY21
KVRKTQKRITKKNPK	DDX60L	1156	Q5H9U9
KKQRKEKEKILLQKR	PDCD7	391	Q8N8D1
RNKQIKVAIKKIMKR	OR14C36	291	Q8NHC7
KQEKKKLHQKLITKR	EVC2	661	Q86UK5
VRERKKKEKKQKPVL	KTN1	111	Q86UP2
KEVEKKKRSRVKQVL	LARP7	21	Q4G0J3
IKKITKDILKVLNRK	MED12	771	Q93074
KKIQKQLEHLKKLRK	MEFV	421	O15553
AKKIKNLKKKLRQVE	PYM1	151	Q9BRP8
KLQLRKEKKQQKKKR	EIF2B4	36	Q9UI10
KVKQEKVKGKVRRKV	RBBP6	1241	Q7Z6E9
KRRKKRQKLKEKKLL	PRKRIP1	126	Q9H875
RRQKKKKLQERKKWQ	PASD1	536	Q8IV76
RNNIFKKKIDEKKRK	REXO2	211	Q9Y3B8
NRPKVSKKKLKEEKR	FKBP11	181	Q9NYL4
IKKKTVRERLEQIKK	EIF3A	631	Q14152
EAKLKKRKPRVKKEN	CHD2	1336	O14647
KRLKKMKELEKQKRI	CCDC191	716	Q8NCU4
LKKEQKKRQKERLKA	CEP350	2071	Q5VT06
KKKIKREVKILENLR	CSNK2A2	76	P19784
KLKKRALKLQQKRQK	BLOC1S6	131	Q9UL45
KMKKLDKILAKKQRR	FSIP1	121	Q8NA03
KKQQKIKEKLRIRTK	IQCF2	31	Q8IXL9
KNKVKKRKLKIIRQG	GPATCH2	206	Q9NW75
EEKALKKIRRKIKNK	CREB3L2	291	Q70SY1
TAEQRKVKKIKKLKE	PRPF3	521	O43395
KIRKKGKIERKQKTD	FANCD2	861	Q9BXW9
LKNVRKKRFRKTQKK	TAF7L	226	Q5H9L4
KKERKKKKQVTNIIS	SNX29P2	101	Q8IUI4
NLLEKKKNQRKIRIK	SEL1L2	66	Q5TEA6
KAVNKVKKKAKRILQ	GPAM	161	Q9HCL2
RKQKKERKQELKLLQ	PRC1	111	O43663
KKKQKRQENIAKAKR	SMIM15	56	Q7Z3B0
RNKKILNKKKLKRKQ	MYCBP2	101	O75592
QNRRVKEKKVINKLK	HOXA13	371	P31271
KKNREEQVQKKKKIL	ANKHD1	821	Q8IWZ3
KKKILKELQKVERQL	ANKHD1	831	Q8IWZ3
KQKLLRKLDRLEKKK	CIR1	221	Q86X95
ESNNKEKKIQRKKRK	CIR1	281	Q86X95
QNKQKKRRKKKKKVL	TIMELESS	526	Q9UNS1
KRRKKKKKVLDQAIV	TIMELESS	531	Q9UNS1
RKKRAKETLEKKKLL	MTRFR	141	Q9H3J6
KKKKRKREKQLSQTQ	TCF7L1	421	Q9HCS4
KKMRNRIIKNEVKKL	RPL14	116	P50914
CFVNKQRKRKLKRKK	IGSF9B	746	Q9UPX0
KLKKKQKRQAELLEK	SRPK2	271	P78362
LKRKIQKKEAKKLAQ	TTC3	771	P53804
IQERLKSLKKKIKKV	TTC3	1566	P53804
QGKKKRKKKRLVINL	TTLL6	51	Q8N841
IKTKRKRKKQRVKIA	TFPI	281	P10646
KNAKLKQKRRKIKTE	NSD3	1301	Q9BZ95
EKRLKQKIKVLKKNG	ZCCHC7	391	Q8N3Z6
KKQIREPVDLQKKKK	ZNF148	131	Q9UQR1
QKKKKRKQRSPAKIL	ZNF148	141	Q9UQR1
QKRKKKLRKLLKRLQ	SULF2	701	Q8IWU5
KKKKKRKQETQRAVE	USP36	956	Q9P275
KQDKTVRKLKKQLKV	MYO5A	1421	Q9Y4I1
VKQSKAQKKKRKQER	MYO9B	1611	Q13459